FDA is really serious about using genuine real-world data to speed up drug trials, not to mention (from the patient standpoint) this kind of data collection could lead to greater safety in drugs that have already been approved. We've recently seen several drugs that turned out not to be so safe after all...

https://www.fiercebiotech.com/medtech/using-r...d=48083647

And this could be fantastic for IPIX down the road -- when they see that Brilacidin has no systemic absorption or side effects from Bril-OM rinse.